Mark P. Atlas
Experienced in Hemolytic Anemia

Dr. Mark P. Atlas

Pediatric Hematology Oncology
Northwell Health
Cohen Children's Northwell Health Physician Partners Pediatric Neurology
2001 Marcus Avenue, Suite W290, 
Lake Success, NY 
On Staff At
Experienced in Hemolytic Anemia
Northwell Health
Cohen Children's Northwell Health Physician Partners Pediatric Neurology
2001 Marcus Avenue, Suite W290, 
Lake Success, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mark Atlas is a Pediatric Hematologist Oncology provider in Lake Success, New York. Dr. Atlas is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Optic Glioma, Glioma, Medulloblastoma, and Acute Lymphoblastic Leukemia (ALL).

His clinical research consists of co-authoring 14 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Albert Einstein College Of Medicine
Residency
Children's Hospital of Philadelphia
Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in NY
Board Certifications
American Board Of Pediatrics/Hematology-Oncology
Fellowships
Lurie Children's Hospital of Chicago
Hospital Affiliations
North Shore University Hospital
Hofstra/Northwell School Of Medicine/Nursing
Long Island Jewish Medical Center
Cancer Institute
Languages Spoken
English
French
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northwell Health
  • INSURANCE PLAN
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

Cohen Children's Northwell Health Physician Partners Pediatric Neurology
2001 Marcus Avenue, Suite W290, Lake Success, NY 11042
Call: 516-465-5255
Other Locations
Cohen Children's Northwell Health Physician Partners at Lake Success
1991 Marcus Avenue, Suite M100, Lake Success, NY 11042
Call: 718-470-3460
Northwell Health Pediatric Hematology/Oncology & Stem Cell Transplant
269-01 76th Avenue, Suite 255, New Hyde Park, NY 11040
Call: 718-470-3460

Additional Areas of Focus

Dr. Atlas has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Managed Access Program (MAP) Cohort Treatment Plan CBYL719F12001M to Provide Access to Alpelisib (BYL719) for Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Managed Access Program (MAP) Cohort Treatment Plan CBYL719F12001M to Provide Access to Alpelisib (BYL719) for Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Enrollment Status: Available
Publish Date: December 02, 2025
Intervention Type: Drug
A Phase 3 Study of Selumetinib (NSC# 748727) or Selumetinib in Combination With Vinblastine for Non-NF1, Non-TSC Patients With Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations
A Phase 3 Study of Selumetinib (NSC# 748727) or Selumetinib in Combination With Vinblastine for Non-NF1, Non-TSC Patients With Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations
Enrollment Status: Active_not_recruiting
Publish Date: November 19, 2025
Intervention Type: Other, Procedure, Drug
Study Drugs: Selumetinib, Vinblastine
Study Phase: Phase 3
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Procedure, Drug
Study Drugs: Carboplatin, Selumetinib Sulfate, Vincristine Sulfate
Study Phase: Phase 3
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Enrollment Status: Active_not_recruiting
Publish Date: October 27, 2025
Intervention Type: Drug, Radiation, Biological, Other
Study Drugs: Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Vincristine
Study Phase: Phase 3
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children With Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 18, 2025
Intervention Type: Other, Procedure
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Enrollment Status: Active_not_recruiting
Publish Date: August 12, 2025
Intervention Type: Drug, Procedure, Radiation, Other
Study Drugs: Cisplatin, Cyclophosphamide, Lomustine, Vincristine, Vincristine Sulfate
Study Phase: Phase 2
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
Enrollment Status: Completed
Publish Date: July 05, 2024
Intervention Type: Drug
Study Drugs: Mebendazole, Vincristine, Carboplatin, Temozolomide, Bevacizumab, Irinotecan
Study Phase: Phase 1/Phase 2
A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 7 Less Clinical Trials

14 Total Publications

Pediatric Fellows and Their Ability to Meet Minimum Supervision Levels at Graduation.
Pediatric Fellows and Their Ability to Meet Minimum Supervision Levels at Graduation.
Journal: Pediatrics
Published: January 09, 2025
View All 14 Publications
Similar Doctors
Banu Aygun
Elite in Hemolytic Anemia
Dr. Banu Aygun
Pediatric Hematology Oncology
Elite in Hemolytic Anemia
Dr. Banu Aygun
Pediatric Hematology Oncology

Northwell Health Pediatric Hematology/Oncology & Stem Cell Transplant

269-01 76th Avenue, Suite 255, 
New Hyde Park, NY 
 (1.0 miles away)
718-470-3460
Languages Spoken:
English, Turkish
See accepted insurances

Banu Aygun is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Aygun is rated as an Elite provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.

Elite in Hemolytic Anemia
Dr. Nancy S. Green
Pediatric Hematology Oncology
Elite in Hemolytic Anemia
Dr. Nancy S. Green
Pediatric Hematology Oncology
3959 Broadway, Columbia Uni Departmt Peds, 
New York, NY 
 (14.4 miles away)
212-304-7250
Languages Spoken:
English
See accepted insurances

Nancy Green is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Green is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Elite in Hemolytic Anemia
Dr. Sujit S. Sheth
Pediatric Hematology Oncology
Elite in Hemolytic Anemia
Dr. Sujit S. Sheth
Pediatric Hematology Oncology

Weill Medical College Of Cornell

525 E 68th St, 
New York, NY 
 (13.8 miles away)
212-746-3558
Languages Spoken:
English
See accepted insurances

Sujit Sheth is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Sheth is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Thalassemia, Beta Thalassemia, Pyruvate Kinase Deficiency, Splenectomy, and Bone Marrow Transplant.

VIEW MORE HEMOLYTIC ANEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Atlas's expertise for a condition
ConditionClose
    • Distinguished
    • Optic Glioma
      Dr. Atlas is
      Distinguished
      . Learn about Optic Glioma.
      See more Optic Glioma experts
    • Advanced
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Atlas is
      Advanced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Beta Thalassemia
      Dr. Atlas is
      Advanced
      . Learn about Beta Thalassemia.
      See more Beta Thalassemia experts
    • Diffuse Midline Glioma H3 K27M-Mutant
      Dr. Atlas is
      Advanced
      . Learn about Diffuse Midline Glioma H3 K27M-Mutant.
      See more Diffuse Midline Glioma H3 K27M-Mutant experts
    • Embryonal Tumor with Multilayered Rosettes
      Dr. Atlas is
      Advanced
      . Learn about Embryonal Tumor with Multilayered Rosettes.
      See more Embryonal Tumor with Multilayered Rosettes experts
    • Glioma
      Dr. Atlas is
      Advanced
      . Learn about Glioma.
      See more Glioma experts
    • Medulloblastoma
      Dr. Atlas is
      Advanced
      . Learn about Medulloblastoma.
      See more Medulloblastoma experts
    • Experienced
    • Aplastic Anemia
      Dr. Atlas is
      Experienced
      . Learn about Aplastic Anemia.
      See more Aplastic Anemia experts
    • Brain Stem Cancer
      Dr. Atlas is
      Experienced
      . Learn about Brain Stem Cancer.
      See more Brain Stem Cancer experts
    • Classical Hodgkin Lymphoma
      Dr. Atlas is
      Experienced
      . Learn about Classical Hodgkin Lymphoma.
      See more Classical Hodgkin Lymphoma experts
    • Congenital Hemolytic Anemia
      Dr. Atlas is
      Experienced
      . Learn about Congenital Hemolytic Anemia.
      See more Congenital Hemolytic Anemia experts
    • Diencephalic Syndrome
      Dr. Atlas is
      Experienced
      . Learn about Diencephalic Syndrome.
      See more Diencephalic Syndrome experts
    • Ewing Sarcoma
      Dr. Atlas is
      Experienced
      . Learn about Ewing Sarcoma.
      See more Ewing Sarcoma experts
    View All 25 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.